Jizhong Yin, Shuo Yang, Menghang Yang, Bin Chen, Shengxiang Ren. "Ablation of oligo-residual disease to prolong progression-free survival in EGFR -mutant advanced NSCLC patients treated with third-generation EGFR-TKIs.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.8633